Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works

Untitled work

(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works

SF-36 health survey: Manual and interpretation guide

Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424 · see citing works

The american college of rheumatology 1990 criteria for the classification of fibromyalgia

Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563 · see citing works

Untitled work

(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients

Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965 · see citing works

The mini international neuropsychiatric interview

Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,882 · see citing works

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808 · see citing works

Pain assessment: global use of the Brief Pain Inventory.

Cs, C., & Km, R. (1994) · PubMed · Cited by 5,178 · see citing works

The prevalence and characteristics of fibromyalgia in the general population

Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,394 · see citing works

Untitled work

(1991) · PubMed · Cited by 1,837 · see citing works

The Anxiety Disease

Sheehan, D. V. (1984) · Medical Entomology and Zoology · Cited by 883 · see citing works

Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial

Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L., Martin, S. A., Sharma, U., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20983 · Cited by 651 · see citing works

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624 · see citing works

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Raskin, J., Pritchett, Y., Wang, F., D’Souza, D. N., Waninger, A., Iyengar, S., & Wernicke, J. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00061.x · Cited by 531 · see citing works

Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.

Mease, P. J. (2005) · PubMed · Cited by 528 · see citing works

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

Wernicke, J. F., Pritchett, Y., D’Souza, D. N., Waninger, A., Tran, P., Iyengar, S., & Raskin, J. (2006) · Neurology · doi:10.1212/01.wnl.0000240225.04000.1a · Cited by 508 · see citing works

The prevalence of chronic widespread pain in the general population.

Croft, P. R., Rigby, A. S., Boswell, R., Schollum, J. B. W., & Silman, A. J. (1993) · PubMed · Cited by 474 · see citing works

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471 · see citing works

Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and Review

Arnold, L. M., Keck, P. E., & Welge, J. A. (2000) · Psychosomatics · doi:10.1176/appi.psy.41.2.104 · Cited by 447 · see citing works

Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Detke, M. J., Lu, Y., Goldstein, D. J., Hayes, J. R., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0407 · Cited by 384 · see citing works

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆

Russell, J. I., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D. J., Chappell, A. S., & Arnold, L. M. (2008) · Pain · doi:10.1016/j.pain.2008.02.024 · Cited by 367 · see citing works

Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms.

Wolfe, F., Ross, K., Anderson, J. J., & Russell, I. J. (1995) · PubMed · Cited by 341 · see citing works

Comparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of Fibromyalgia

Carette, S., Bell, M. J., Reynolds, W. J., Haraoui, B. P., McCain, G. A., Bykerk, V. P., Edworthy, S. M., Baron, M. G., Koehler, B. E., Fam, A. G., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370106 · Cited by 339 · see citing works

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

Mace, S., & Taylor, D. M. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315 · see citing works

Evaluation of amitriptyline in primary fibrositis. A double‐blind, placebo‐controlled study

Carette, S., McCain, G. A., Bell, D. A., & Fam, A. G. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290510 · Cited by 298 · see citing works

CONGENITAL HEMIHYPERTROPHY AND MALIGNANCY

Benson, P. F., Vulliamy, D. G., & Taubman, J. O. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92360-2 · Cited by 291 · see citing works

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

Hartford, J. T., Kornstein, S. G., Liebowitz, M. R., Pigott, T. A., Russell, J. D., Detke, M. J., Walker, D. J., Ball, S. G., Dunayevich, E., Dinkel, J., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32807fb1b2 · Cited by 286 · see citing works

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 283 · see citing works

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Detke, M. J., Lu, Y., GOLDSTEIN, D. J., McNamara, R. K., & Demitrack, M. A. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00060-2 · Cited by 278 · see citing works

Efficacy of milnacipran in patients with fibromyalgia.

Gendreau, R. M., Thorn, M. D., Gendreau, J., Kranzler, J., Ribeiro, S. C. M., Gracely, R. H., Williams, D. A., Mease, P. J., McLean, S. A., & Clauw, D. J. (2005) · PubMed · Cited by 237 · see citing works

Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors

Peretti, S., Judge, R., & Hindmarch, I. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10944.x · Cited by 236 · see citing works

SSRI safety in overdose.

Barbey, J. T., & Roose, S. P. (1998) · PubMed · Cited by 209 · see citing works

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

Vitton, O., Gendreau, M., Gendreau, J., Kranzler, J., & Rao, S. G. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.622 · Cited by 202 · see citing works

Weight gain

Berken, G. H., Weinstein, D. O., & Stern, W. C. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90031-4 · Cited by 170 · see citing works

The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.

Giardina, E. V., Bigger, J. T., Glassman, A. H., Perel, J. M., & Kantor, S. J. (1979) · Circulation · doi:10.1161/01.cir.60.5.1045 · Cited by 168 · see citing works

Venlafaxine treatment of fibromyalgia

Sayar, K., Aksu, G., Ak, I., & Tosun, M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d112 · Cited by 157 · see citing works

CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION

Glassman, A. H., Bigger, J. T., GGiardina, E., Kantor, S. J., Perel, J., & Davies, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90824-9 · Cited by 156 · see citing works

Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs

Kemmler, G., Hummer, M., Widschwendter, C. G., & Fleischhacker, W. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1305 · Cited by 146 · see citing works

ECG abnormalities in tricyclic antidepressant ingestion

Harrigan, R. A., & Brady, W. J. (1999) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(99)90094-3 · Cited by 139 · see citing works

An Evaluation of the Cardiovascular Safety Profile of Duloxetine

Wernicke, J., Lled, A., Raskin, J., Kajdasz, D. K., & Wang, F. (2007) · Drug Safety · doi:10.2165/00002018-200730050-00007 · Cited by 131 · see citing works

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

David, P., Wang, F., Mallinckrodt, C. H., Walker, D. J., & Detke, M. J. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.03.004 · Cited by 128 · see citing works

Duloxetine and Other Antidepressants in the Treatment of Patients with Fibromyalgia

Arnold, L. M. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00178.x · Cited by 127 · see citing works

The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction.

Vohra, J., Burrows, G. D., Hunt, D. U., & Sloman, G. (1975) · PubMed · Cited by 126 · see citing works

Management of Fibromyalgia

Cohn, L. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00021 · Cited by 121 · see citing works

Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain

Raskin, J., Smith, T. R., Wong, K., Pritchett, Y., D’Souza, D. N., Iyengar, S., & Wernicke, J. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.29 · Cited by 119 · see citing works

A retrospective pooled analysis of duloxetine safety in 23 983 subjects

Gahimer, J., Wernicke, J., Yalcin, I., Ossanna, M. J., Wulster-Radcliffe, M. C., & Viktrup, L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x162719 · Cited by 102 · see citing works

Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.

Koponen, H., Allgulander, C., Erickson, J., Dunayevich, E., Pritchett, Y., Detke, M., Ball, S., & Russell, J. M. (2007) · The Primary Care Companion to the Journal Clinical Psychiatry · doi:10.4088/pcc.v09n0203 · Cited by 101 · see citing works

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

Chappell, A. S. (2008) · International Journal of General Medicine · doi:10.2147/ijgm.s3979 · Cited by 99 · see citing works

Duloxetine in the prevention of relapse of major depressive disorder: Double-blind placebo-controlled study

Perahia, D. G., Gilaberte, I., Wang, F., Wiltse, C. G., Huckins, S. A., Clemens, J. W., Montgomery, S. A., Montejo, A. L., & Detke, M. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.346 · Cited by 94 · see citing works

Management of Fibromyalgia

Leventhal, L. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-11-199912070-00009 · Cited by 90 · see citing works

Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.

Hider, S., Bruce, I. N., Silman, A. J., & Symmons, D. P. M. (2005) · PubMed · Cited by 75 · see citing works

An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain

Wernicke, J., Wang, F., Pritchett, Y., Smith, T. R., Raskin, J., D’Souza, D. N., Iyengar, S., & Chappell, A. S. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00258.x · Cited by 59 · see citing works

Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.

Sala, M., Coppa, F., Cappucciati, C., Brambilla, P., d'Allio, G., Caverzasi, E., Barale, F., & Ferrari, G. M. D. (2006) · PubMed · Cited by 53 · see citing works

Effects of the Antidepressant Duloxetine on Body Weight

Wise, T. N., David, P., Pangallo, B. A., Losin, W. G., & Wiltse, C. G. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0503 · Cited by 48 · see citing works

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial

Wernicke, J., Raskin, J., Rosen, A. S., Pritchett, Y., D’Souza, D. N., Iyengar, S., Knopp, K. L., & Le, T. K. (2006) · Current Therapeutic Research · doi:10.1016/j.curtheres.2006.10.001 · Cited by 26 · see citing works

Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome

Häuser, W., Petzke, F., & Sommer, C. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.01.002 · Cited by 216 · see citing works

Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levels

Younger, J., Noor, N., McCue, R., & Mackey, S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37734 · Cited by 209 · see citing works

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome

Häuser, W., Urrútia, G., Tort, S., Üçeyler, N., & Walitt, B. T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010292 · Cited by 164 · see citing works

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia

Welsch, P., Üçeyler, N., Klose, P., Walitt, B. T., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010292.pub2 · Cited by 152 · see citing works

Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials

Chadwick, A. L., Hurley, R. W., & Benzon, H. T. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002426 · Cited by 108 · see citing works

A Review of Duloxetine 60 mg Once‐Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain

Pergolizzi, J. V., Raffa, R. B., Taylor, R., Rodriguez, G., Nalamachu, S. R., & Langley, P. C. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00578.x · Cited by 108 · see citing works

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

Rodrígues-Amorím, D., Olivares, J. M., Spuch, C., & Baltanás, T. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.554899 · Cited by 99 · see citing works

Central amplification and fibromyalgia: Disorder of pain processing

Petersel, D. L., Dror, V., & Cheung, R. Y. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22512 · Cited by 80 · see citing works

Advances in the Assessment of Fibromyalgia

Williams, D. A., & Schilling, S. G. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.05.007 · Cited by 78 · see citing works

Pharmacotherapy of fibromyalgia

Mease, P. J., Dundon, K. M. W., & Sarzi‐Puttini, P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.01.015 · Cited by 72 · see citing works

Management of Fibromyalgia Syndrome in 2016

Okifuji, A., Gao, J., Bokat, C. E., & Hare, B. D. (2016) · Pain Management · doi:10.2217/pmt-2016-0006 · Cited by 66 · see citing works

Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study

Goldenberg, D. L., Clauw, D. J., Palmer, R. H., Mease, P. J., Chen, W., & Gendreau, R. M. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00755.x · Cited by 65 · see citing works

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis

Vollmer, T. L., Robinson, M. J., Risser, R. C., & Malcolm, S. K. (2013) · Pain Practice · doi:10.1111/papr.12127 · Cited by 64 · see citing works

The clinical relevance of genetic susceptibility to osteoarthritis

Valdes, A. M., & Spector, T. D. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.08.005 · Cited by 61 · see citing works

Clinically Relevant Outcomes Based on Analysis of Pooled Data from 2 Trials of Duloxetine in Patients with Knee Osteoarthritis

Hochberg, M. C., Wohlreich, M. M., Gaynor, P. J., HANNA, S., & Risser, R. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110307 · Cited by 59 · see citing works

Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia

Wolfe, F., Walitt, B. T., Katz, R. S., Lee, Y. C., Michaud, K. D., & Häuser, W. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00234.x · Cited by 55 · see citing works

Management of Fibromyalgia Syndrome: Review of Evidence

Okifuji, A., & Hare, B. D. (2013) · Pain and Therapy · doi:10.1007/s40122-013-0016-9 · Cited by 49 · see citing works

Maintenance of Effect of Duloxetine in Patients with Chronic Low Back Pain: A 41-week Uncontrolled, Dose-blinded Study

Skljarevski, V., Zhang, S., Chappell, A. S., Walker, D. J., Murray, I., & Bačkonja, M. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00836.x · Cited by 49 · see citing works

Preparation and optimization of various parameters of enteric coated pellets using the Taguchi L9 orthogonal array design and their characterization

Shravani, D., Lakshmi, P. K., & Balasubramaniam, J. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.04.005 · Cited by 45 · see citing works

Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials

Alorfi, N. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1017129 · Cited by 40 · see citing works

Treating Pain in Addicted Patients: Recommendations from an Expert Panel

Cheatle, M. D., Comer, D., Wunsch, M. J., Skoufalos, A., & Reddy, Y. (2013) · Population Health Management · doi:10.1089/pop.2013.0041 · Cited by 31 · see citing works

Pharmacotherapy of Fibromyalgia

Mease, P. J., & Choy, E. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.06.007 · Cited by 31 · see citing works

Opioid Therapy in Patients with Chronic Noncancer Pain: Diagnostic and Clinical Challenges

Cheatle, M. D., & O’Brien, C. P. (2011) · Advances in psychosomatic medicine · doi:10.1159/000324067 · Cited by 30 · see citing works

New and emerging therapeutic agents for the treatment of fibromyalgia: an update

Recla, J. M. (2010) · Journal of Pain Research · doi:10.2147/jpr.s6792 · Cited by 29 · see citing works

Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

Spaeth, M., Alegre, C., Perrot, S., Wang, Y., Guinta, D., Alvarez-Horine, S., Russell, I. J., & the Sodium Oxybate Fibromyalgia Study Group (2013) · Arthritis Research & Therapy · doi:10.1186/ar4375 · Cited by 20 · see citing works

Combining Opioid and Adrenergic Mechanisms for Chronic Pain

Smith, H. S., Raffa, R. B., Pergolizzi, J. V., Taylor, R., & Tallarida, R. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2788 · Cited by 20 · see citing works

Effects of Duloxetine on Norepinephrine and Serotonin Transporter Activity in Healthy Subjects

Chappell, J. C., Eisenhofer, G., Owens, M. J., Haber, H. E., Lachno, D. R., Dean, R. A., Knadler, M. P., Nemeroff, C. B., Mitchell, M. I., Detke, M. J., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000061 · Cited by 19 · see citing works

Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial

Clauw, D. J., Mease, P. J., Palmer, R. H., Trugman, J. M., & Wang, Y. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4268 · Cited by 18 · see citing works

Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies

Wachholtz, A., Gonzalez, Boyer, A., Naqvi, Rosenbaum, V., & Ziedonis (2011) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s12944 · Cited by 16 · see citing works

Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data

Wang, G., Bi, L., Li, X.-P., Li, Z., Zhao, D., Chen, J., He, D., Wang, C.-N., Wu, T., Dueñas, H., et al. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2527-y · Cited by 15 · see citing works

Current progress in the pharmacological therapy of fibromyalgia

Rao, S. G. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903203771 · Cited by 15 · see citing works

An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia

Murakami, M., Osada, K., Ichibayashi, H., Mizuno, H., Ochiai, T., Ishida, M., Alev, L., & Nishioka, K. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1245237 · Cited by 14 · see citing works

Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients

Lipkovich, I. A., Choy, E., Wambeke, P. V., Deberdt, W. G., & Sagman, D. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-450 · Cited by 12 · see citing works

Antidepressants and Incident Hypertension in Primary Care Patients

Breeden, M. A., Brieler, J. A., Salas, J., & Scherrer, J. F. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.01.170234 · Cited by 12 · see citing works

Duloxetine 60 mg/day for the prevention of depressive recurrences:post hocanalyses from a recurrence prevention study

Kelin, K., Berk, M., Spann, M., Sagman, D., Raskin, J., Walker, D. J., & David, P. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02374.x · Cited by 11 · see citing works

Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater

Kim, Y., Pradhan, R., Paudel, B. K., Choi, J. Y., Im, H. T., & Kim, J. O. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0590-y · Cited by 11 · see citing works

Duloxetine

Curran, M. P. (2009) · Drugs · doi:10.2165/00003495-200969090-00006 · Cited by 10 · see citing works

Single-agent duloxetine ingestions

Jacob, J., Albert, D., & Heard, K. J. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112462726 · Cited by 8 · see citing works

Psychopharmakotherapeutische Ansätze bei somatoformen Störungen und funktionellen Körpersyndromen

Kapfhammer, H. (2012) · Der Nervenarzt · doi:10.1007/s00115-011-3446-9 · Cited by 8 · see citing works

Fibromyalgie

Späth, M. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0783-9 · Cited by 5 · see citing works

Antidepressant treatment and blood pressure control in patients with comorbid depression and treatment resistant hypertension

Breeden, M. A., Gillis, A., Salas, J., & Scherrer, J. F. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110692 · Cited by 5 · see citing works

Quality of Life in Patients with Fibromyalgia

Ishak, I. (2013) · International Journal of Clinical Psychiatry and Mental Health · doi:10.12970/2310-8231.2013.01.01.1 · Cited by 4 · see citing works

Evaluation of Duloxetine for Chronic Pain Conditions

Mease, P. J., Walker, D. J., & Alaka, K. (2011) · Pain Management · doi:10.2217/pmt.11.4 · Cited by 3 · see citing works

Applications of Neuromodulation in Pain Management

Knotková, H., Greenberg, A., Soto, E., & Cruciani, R. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1408-1_15 · Cited by 2 · see citing works

Addressing Unmet Needs in Osteoarthritis

Henrotin, Y. E., Marty, M., & Mobasheri, A. (2013) · Cited by 1 · see citing works

Novel strategies and future landmarks in the treatment of irritable bowel syndrome

Róka, R., Gecse, K. B., & Wittmann, T. (2009) · Therapy · doi:10.2217/thy.09.22 · Cited by 1 · see citing works

A narrative study of the illness experience of fibromyalgia in South Africa.

Cooper, S. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1 · see citing works

Pharmacotherapy of Fibromyalgia: Focus on Duloxetine

Serra, E., & Andréjak, M. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s1162

Costo-efectividad del uso de duloxetina en el tratamiento farmacológico de fibromialgia en México

Rivera, F. C., Ramírez-Gámez, J., Ruíz, I., & Ortiz-Escalante, K. (2013) · Archivos de Neurociencias

Atividade de mediadores lipídicos derivados de ácidos graxos poli-insaturados sobre alterações comportamentais e bioquímicas em um modelo de fibromialgia em camundongos

Klein, C. P. (2014) · Americanae (AECID Library)

Genetics and clinical applications

Williams, C. J. (2013) · doi:10.2217/ebo.12.162

Pre hospital emergency medical services in Maharashtra- primary survey and analysis of response times, care provisioning, user experience and expectations from the PPP project

Shah, U., & Thakur, H. P. (2019) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2019.6.3.9

Medication Treatments

Marcus, D. A., & Deodhar, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1609-9_12

Afecciones reumatológicas de partes blandas

Duró, J. C. (2010) · Elsevier eBooks · doi:10.1016/b978-84-8086-645-3.50041-x

(186) Safety and tolerability of Duloxetine in the treatment of patients with Fibromyalgia: Analysis of 5 studies

Choy, E., Mease, P. J., Kajdasz, D. K., Wohlreich, M. M., Walker, D. J., & Chappell, A. S. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.01.107 · Cited by 3 · see citing works

A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

Chappell, A. S., Littlejohn, G. O., Kajdasz, D. K., Scheinberg, M. A., D’Souza, D. N., & Moldofsky, H. (2009) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31819be587 · Cited by 72 · see citing works

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Choy, E. H. S., Mease, P. J., Kajdasz, D. K., Wohlreich, M. M., Crits-Christoph, P., Walker, D. J., & Chappell, A. S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1203-2 · Cited by 47 · see citing works

An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia

Murakami, M., Osada, K., Ichibayashi, H., Mizuno, H., Ochiai, T., Ishida, M., Alev, L., & Nishioka, K. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1245237 · Cited by 14 · see citing works

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

Chappell, A. S. (2008) · International Journal of General Medicine · doi:10.2147/ijgm.s3979 · Cited by 99 · see citing works